Market overview
The global telemedicine market is worth USD 103 bn in 2026 and is forecast to reach USD 348 bn by 2036, growing at a 13.0% CAGR. United States is the largest country market and Video consultation is the largest by service segment.
| Scope | Remote medical consultations delivered by video, phone or chat, including platform fees and visit revenue from telehealth providers and telemedicine software. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 90.0 bn |
| Value 2026 | USD 103 bn |
| Value 2036 | USD 348 bn |
| CAGR 2026-2036 | 13.0% |
| Volume 2026 | 2,032 million consultations |
| Volume 2036 | 6,243 million consultations |
| Average price 2026 | USD 50.5 per consultation |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Telemedicine market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 103 bn |
| 2027 | USD 116 bn |
| 2028 | USD 131 bn |
| 2029 | USD 148 bn |
| 2030 | USD 167 bn |
| 2031 | USD 189 bn |
| 2032 | USD 214 bn |
| 2033 | USD 241 bn |
| 2034 | USD 273 bn |
| 2035 | USD 308 bn |
| 2036 | USD 348 bn |
Telemedicine market segmentation
By service
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Video consultation | 46.0% | 45.6% | USD 47.2 bn | 12.9% |
| Phone and audio | 18.0% | 10.3% | USD 18.5 bn | 6.8% |
| Chat and asynchronous | 14.0% | 18.1% | USD 14.4 bn | 15.9% |
| Platform software and tools | 22.0% | 26.0% | USD 22.6 bn | 14.9% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Primary care | 34.0% | 30.8% | USD 34.9 bn | 11.9% |
| Mental health | 22.0% | 26.0% | USD 22.6 bn | 14.9% |
| Specialist care | 20.0% | 19.8% | USD 20.5 bn | 12.9% |
| Chronic disease | 14.0% | 15.1% | USD 14.4 bn | 13.9% |
| Urgent care and others | 10.0% | 8.3% | USD 10.3 bn | 10.9% |
By delivery
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Real-time video | 52.0% | 48.0% | USD 53.4 bn | 12.1% |
| Store-and-forward | 12.0% | 12.0% | USD 12.3 bn | 13.0% |
| Remote monitoring integration | 20.0% | 24.0% | USD 20.5 bn | 15.1% |
| AI-assisted triage | 16.0% | 16.0% | USD 16.4 bn | 13.0% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Patients direct | 38.0% | 38.0% | USD 39.0 bn | 13.0% |
| Hospitals and providers | 34.0% | 32.0% | USD 34.9 bn | 12.3% |
| Payers and employers | 28.0% | 30.0% | USD 28.7 bn | 13.8% |
By component
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Services | 56.0% | 50.0% | USD 57.5 bn | 11.7% |
| Software | 30.0% | 34.0% | USD 30.8 bn | 14.4% |
| Hardware | 14.0% | 16.0% | USD 14.4 bn | 14.5% |
Top 25 countries for telemedicine by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 95.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 41.0 bn | 40.0% | USD 113 bn | 10.7% |
| 2 | China | USD 14.4 bn | 14.0% | USD 61.6 bn | 15.7% |
| 3 | India | USD 8.2 bn | 8.0% | USD 49.5 bn | 19.7% |
| 4 | United Kingdom | USD 5.1 bn | 5.0% | USD 14.3 bn | 10.8% |
| 5 | Germany | USD 4.1 bn | 4.0% | USD 12.5 bn | 11.8% |
| 6 | Brazil | USD 4.1 bn | 4.0% | USD 16.0 bn | 14.6% |
| 7 | Canada | USD 3.1 bn | 3.0% | USD 8.4 bn | 10.5% |
| 8 | Australia | USD 2.6 bn | 2.5% | USD 7.7 bn | 11.6% |
| 9 | France | USD 2.6 bn | 2.5% | USD 7.7 bn | 11.6% |
| 10 | Japan | USD 2.6 bn | 2.5% | USD 8.4 bn | 12.5% |
| 11 | Spain | USD 2.4 bn | 2.3% | USD 7.0 bn | 11.4% |
| 12 | Mexico | USD 1.4 bn | 1.4% | USD 6.0 bn | 15.4% |
| 13 | Italy | USD 1.0 bn | 1.0% | USD 3.1 bn | 11.5% |
| 14 | Netherlands | USD 841 mn | 0.8% | USD 2.5 bn | 11.5% |
| 15 | South Korea | USD 708 mn | 0.7% | USD 2.1 bn | 11.6% |
| 16 | Saudi Arabia | USD 626 mn | 0.6% | USD 2.6 bn | 15.4% |
| 17 | Russia | USD 554 mn | 0.5% | USD 1.6 bn | 11.4% |
| 18 | Indonesia | USD 503 mn | 0.5% | USD 2.1 bn | 15.3% |
| 19 | Sweden | USD 462 mn | 0.5% | USD 1.4 bn | 11.4% |
| 20 | Turkey | USD 421 mn | 0.4% | USD 1.8 bn | 15.5% |
| 21 | Singapore | USD 390 mn | 0.4% | USD 1.7 bn | 15.7% |
| 22 | Poland | USD 369 mn | 0.4% | USD 1.6 bn | 15.6% |
| 23 | Belgium | USD 349 mn | 0.3% | USD 1.0 bn | 11.6% |
| 24 | Switzerland | USD 328 mn | 0.3% | USD 975 mn | 11.5% |
| 25 | Taiwan | USD 308 mn | 0.3% | USD 940 mn | 11.8% |
| Rest of world | USD 4.2 bn | 4.1% | USD 12.7 bn | 11.8% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Teladoc Health
- Amwell
- Doctolib
- Ping An Good Doctor
- Philips
- JD Health
- Alibaba Health
Group 2: Regional and specialist players
- Hims and Hers
- Included Health
- Doximity
- Practo
- Talkspace
- LifeMD
- Kry
- Halodoc
- Doctor Anywhere
- Ro
Group 3: Emerging and niche players
- Zocdoc
- MDLive
- Mfine
- K Health
- Maven Clinic
- Cerebral
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the telemedicine market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 13.0% is calculated from the resulting values.
The market is divided by service, by application, by delivery, by end user, by component. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the telemedicine market?
The global telemedicine market is estimated at USD 90.0 bn in 2025 and USD 103 bn in 2026.
How fast will the telemedicine market grow?
It is forecast to reach USD 348 bn by 2036, a compound annual growth rate of 13.0% from 2026, an increase of USD 246 bn.
Which country is the largest market for telemedicine?
United States is the largest market by revenue at USD 41.0 bn in 2026, 40.0% of the global total. The three largest countries together hold 62.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 19.7% a year from 2026 to 2036.
Which telemedicine segment is largest?
In the by service split, Video consultation is the largest segment with 46.0% of 2026 revenue.
Who are the leading telemedicine companies?
Global leaders include Teladoc Health, Amwell, Doctolib, Ping An Good Doctor.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- In Vitro DiagnosticsUSD 108 bn · 5.5% CAGR
- Diabetes DrugsUSD 97.5 bn · 5.0% CAGR
- Peptide TherapeuticsUSD 110 bn · 12.0% CAGR
- Generic InjectableUSD 93.3 bn · 6.3% CAGR
- Contract Research OrganizationUSD 91.8 bn · 8.0% CAGR
- Clinical TrialsUSD 118 bn · 7.0% CAGR
- Cardiovascular DevicesUSD 83.8 bn · 7.0% CAGR
- VaccinesUSD 80.6 bn · 7.0% CAGR